We can't find the internet
Attempting to reconnect
28170.1 PFLS-LS
28170.1 PFLS-LS
Résumé
Enabling highly efficient, easy to manufacture antibody-drug conjugates (ADCs) with low side-effects
Textes supplémentaires
Abstract
In this proof-of-concept study we aim to evaluate the in-vitro and in-vivo properties of antibody-drug conjugates (ADCs) that are generated by a new site-specific conjugation method to native antibodies. Our technology aims to enable highly efficient, easy to manufacture ADCs with low side-effects.
Participants
Philipp Spycher
Kontaktperson
philipp.spycher@psi.ch
PSI, Paul Scherrer Institut Philipp Spycher OIPA 8 5232 Villigen AG CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-06-30
- Date de fin
- 2019-06-30
- Coûts totaux approuvés
- CHF 178716.00
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- P004 Biochemistry, Metabolism 100.0%